Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and Synthesis of Novel Imidazo[4,5-c]pyridine Derivatives, Evaluation of Their Activity Against Hepatitis C Virus and In Silico Prediction of Their Binding Mode to NS4B Protein.

ChemMedChem·2026
Same author

Double-Stapled Peptide Scan Yields Potent Fusion Inhibitors of Respiratory Syncytial Virus.

Journal of medicinal chemistry·2026
Same author

L-Dopa Decarboxylase Mediates Apoptosis Through Regulation of PI3K/AKT Pathway in Response to DENV Infection.

BioFactors (Oxford, England)·2026
Same author

Eligibility for lecanemab treatment in a French memory clinic setting.

Journal of neurology·2026
Same author

Assessment of medication-related risks for mortality prediction in Alzheimer's disease.

Maturitas·2026
Same author

Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study.

Alzheimer's research & therapy·2026

Related Experiment Video

Updated: Jun 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus controls interferon production through PKR activation.

Noëlla Arnaud1, Stéphanie Dabo, Patrick Maillard

  • 1Institut Pasteur, Unité Hépacivirus et Immunité Innée, Paris, France.

Plos One
|May 21, 2010
PubMed
Summary

Hepatitis C virus (HCV) uses protein kinase R (PKR) to suppress interferon (IFN) production via the RIG-I/MAVS pathway. Inhibiting PKR boosts innate immunity and reduces HCV.

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Experiment Videos

Last Updated: Jun 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) poorly induces interferon (IFN), a key antiviral cytokine.
  • This impaired IFN induction is partly due to the HCV NS3/4A protease cleaving MAVS, a crucial adapter in the RIG-I/MAVS pathway.
  • Early events in HCV-induced IFN production and regulation remain incompletely understood.

Purpose of the Study:

  • To investigate the early dynamics of IFN induction during HCV infection.
  • To elucidate the role of protein kinase R (PKR) in HCV-mediated suppression of IFN production.
  • To explore the potential of targeting PKR for boosting innate immunity against HCV.

Main Methods:

  • Utilized the JFH1 strain of HCV and a novel permissive Huh7.25.CD81 cell line dependent on TRIM25 for RIG-I/MAVS signaling.
  • Assessed IFN induction, viral RNA and protein levels, and translation efficiency using reporter assays.
  • Investigated the phosphorylation status of PKR and eIF2alpha, and employed PKR silencing and pharmacological inhibitors.

Main Results:

  • HCV infection initially induced IFN, but this declined within 12 hours, more rapidly at the protein than RNA level, indicating translational control.
  • HCV specifically inhibited eIF2alpha-dependent translation and triggered PKR and eIF2alpha phosphorylation.
  • PKR silencing or inhibition restored IFN induction and, importantly, reduced HCV yields in cells with functional RIG-I/MAVS signaling.

Conclusions:

  • HCV actively utilizes PKR to suppress IFN induction via the RIG-I/MAVS pathway, representing a novel viral immune evasion mechanism.
  • PKR inhibition emerges as a potential therapeutic strategy to enhance innate antiviral immunity against HCV.
  • This study provides the first evidence of PKR's role in restraining HCV-induced IFN production.